
Glimitoss M Forte 3mg/1000mg Tablet SR
Marketer
Minitoss Medicines
Salt Composition
Glimepiride (3mg) + Metformin (1000mg)
Overview Glimitoss M Forte 3mg/1000mg Tablet SR
Diabetol Duo 3mg/1000mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabetol Duo with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular mealtimes and carry a rapid-acting glucose source like sweets or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your physician of any history of heart disease before starting treatment, as suitability may be affected. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood sugar monitoring is essential, and your doctor might recommend blood tests to track blood cell counts and liver function.
Uses of Glimitoss M Forte 3mg/1000mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimitoss M Forte 3mg/1000mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimitoss M Forte 3mg/1000mg sustained-release tablet whole; do not break, crush, or chew it. Administer this medication with a meal.
Common Side effects of Glimitoss M Forte 3mg/1000mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimitoss M Forte 3mg/1000mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Glimitoss M Forte 3mg/1000mg Sustained-Release Tablet with a meal.
How Glimitoss M Forte 3mg/1000mg Tablet SR works:
Glimepiride/Metformin 3mg/1000mg Extended-Release Tablets (Glimitoss M Forte) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Glimitoss M Forte 3mg/1000mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimitoss M Forte 3mg/1000mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Prolonged-release Glimitoss M Forte 3mg/1000mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms manifest.
KidneyCAUTION
Patients with kidney impairment should use Glimitoss M Forte 3mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimitoss M Forte 3mg/1000mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Exercise caution when prescribing Glimitoss M Forte 3mg/1000mg SR tablets to individuals with hepatic impairment. Dosage modifications may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate treatment with a reduced Glimitoss M Forte 3mg/1000mg SR tablet dosage; avoid use in those with severe liver disease.
What if you forget to take Glimitoss M Forte 3mg/1000mg Tablet SR :
Should you forget a Glimitoss M Forte 3mg/1000mg SR Tablet dose, take it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimitoss M Forte 3mg/1000mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
